Michel Wurm, M.D. to present the positive results of Pharmaleads’ Phase 2a, proof of concept clinical study of PL37 in painful diabetic neuropathy at the International Association for the Study of Pain (IASP) World Congress in Yokohama.

News - Latest posts

Discover our publications
Press & media coverage
Contact & find us

Pharmaleads SA
11, rue Watt
75013 Paris

Tel: +33 (0)1 44 06 70 00
Fax: +33 (0)1 44 06 60 99
info@pharmaleads.com

Get the access map